Back
Lumos Pharma Quote, Financials, Valuation and Earnings
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.
Sell
38
LUMO
Lumos Pharma
Last Price:
3.95
Seasonality Move:
-11.54%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Lumos Pharma Price Quote
$3.95
+0.13 (+3.4%)
(Updated: September 27, 2024 at 6:55 PM ET)
Lumos Pharma Key Stats
Sell
38
Lumos Pharma (LUMO)
is a Sell
Day range:
$3.73 - $4.15
52-week range:
$1.37 - $4.55
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.75
P/B ratio:
3.02%
Volume:
40K
Avg. volume:
123K
1-year change:
37.41%
Market cap:
$31M
Revenue:
$2.1M
EPS:
$-4.43
How Much Does Lumos Pharma Make?
-
How Much Are Lumos Pharma's Sales Annually?
LUMO Revenues are $2.1M -
How Much Profit Does Lumos Pharma's Make A Year?
LUMO net income is -$34M
Is Lumos Pharma Growing As A Company?
-
What Is Lumos Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.07% -
What Is Lumos Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Lumos Pharma Stock Price Performance
-
Did Lumos Pharma Stock Go Up Last Month?
Lumos Pharma share price went down by -0.78% last month -
Did LUMO's Share Price Rise Over The Last Year?
LUMO share price rose by 37.41% over the past 1 year
What Is Lumos Pharma 52-Week High & Low?
-
What Is Lumos Pharma’s 52-Week High Share Price?
Lumos Pharma has traded as high as $4.55 over the past 52 weeks -
What Is Lumos Pharma’s 52-Week Low Share Price?
Lumos Pharma has traded as low as $1.37 over the past 52 weeks
Lumos Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Lumos Pharma?
-
How Much Debt Does Lumos Pharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Lumos Pharma Have?
Cash and short term investments quarterly total is $16.8M -
What Is Lumos Pharma’s Book Value Per Share?
Book value per share is 1.26
Is Lumos Pharma Cash Flow Positive?
-
What Is LUMO Cash Flow From Operations?
Cash flow from operations (TTM) is -$34.5M -
What Is Lumos Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $302K -
What Is Lumos Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $13.1M
Lumos Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
LUMO return on invested capital is -133.22% -
What Is Lumos Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -92.04% -
What Is LUMO Return On Equity?
ROE is a measure of profitability and is -133.22%
Lumos Pharma Earnings Date & Stock Price
-
What Is Lumos Pharma's Stock Price Today?
A single share of LUMO can be purchased today for 3.82 -
What Is Lumos Pharma’s Stock Symbol?
Lumos Pharma trades on the nasdaq under the ticker symbol: LUMO -
When Is Lumos Pharma’s Next Earnings Date?
The next quarterly earnings date for Lumos Pharma is scheduled on November 7, 2024 -
When Is LUMO's next ex-dividend date?
Lumos Pharma's next ex-dividend date is September 28, 2024 -
How To Buy Lumos Pharma Stock?
You can buy Lumos Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Lumos Pharma Competitors
-
Who Are Lumos Pharma's Competitors?
Below is a list of companies who compete with Lumos Pharma or are related in some way:
Lumos Pharma Dividend Yield
-
What Is LUMO Dividend Yield?
Lumos Pharma’s dividend yield currently is 0% -
What Is Lumos Pharma’s Payout Ratio?
Lumos Pharma’s payout ratio is 0% -
When Did Lumos Pharma Last Pay A Dividend?
The latest dividend pay date is September 28, 2024 -
What Is Lumos Pharma’s Dividend Per Share?
Lumos Pharma pays a dividend of $0.00 per share
Lumos Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 26.04% |
| Revenue: | -7.4% | 290.4% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 20.60 |
| Upside from Last Price: | 439.27% |